High prevalence of dysfibrinogenemia among patients with chronic thromboembolic pulmonary hypertension

The mechanism by which chronic thromboembolic pulmonary hypertension (CTEPH) develops after acute pulmonary thromboembolism is unknown. We previously reported that fibrin from CTEPH patients is relatively resistant to fibrinolysis in vitro. In the present study, we performed proteomic, genomic, and...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Morris, Timothy A., Marsh, James J., Chiles, Peter G., Magaña, Marisa M., Liang, Ni-Cheng, Soler, Xavier, DeSantis, Daniel J., Ngo, Debby, Woods, Virgil L.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Hematology 2009
Matèries:
Thrombosis and Hemostasis
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2738577/
https://ncbi.nlm.nih.gov/pubmed/19420351
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2009-03-208264
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars